Fabry's Disease

Fabry's Disease is the indication for 4 drugs in DrugBank. It is covered by 8 curated, structured indications.

Also known as: Fabry Disease · Fabry · Fabry´s Disease
Classified under: Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Genetic Variation
Nervous System Diseases
Nutritional and Metabolic Diseases
Signs, Symptoms, and General Pathologies
Skin and Subcutaneous Tissue Diseases
Indicated drugs: Agalsidase alfa
Agalsidase beta
Migalastat
Pegunigalsidase alfa

Resolves to

Vocabularies

MeSHM0001191ICD-10E75.21SNOMED CT16652001MedDRA10002458UMLSC0002986

What you can answer from here — as of September 29, 2026

4Indicated drugsWith each drug's targets and mechanism

Listed above

8Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

115Clinical trialsPhase, status and sponsor resolved per trial

2Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Fabry's Disease share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.